 |
PDBsum entry 5jlb
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of setd2 bound to histone h3.3 k36i peptide
|
|
Structure:
|
 |
Histone-lysine n-methyltransferase setd2. Chain: a. Fragment: catalytic domain, unp residues 1434-1711. Synonym: hif-1,huntingtin yeast partner b,huntingtin-interacting protein 1,hip-1,huntingtin-interacting protein b,lysine n- methyltransferase 3a,set domain-containing protein 2,hset2,p231hbp. Engineered: yes. Histone h3.3. Chain: b.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: setd2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: chemically synthesized
|
|
Resolution:
|
 |
|
1.50Å
|
R-factor:
|
0.166
|
R-free:
|
0.190
|
|
|
Authors:
|
 |
H.Li,S.Yang
|
|
Key ref:
|
 |
S.Yang
et al.
(2016).
Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
Genes Dev,
30,
1611-1616.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-Apr-16
|
Release date:
|
02-Nov-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.2.1.1.359
- [histone H3]-lysine(36) N-trimethyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-lysyl36-[histone H3] + 3 S-adenosyl-L-methionine = N6,N6,N6- trimethyl-L-lysyl36-[histone H3] + 3 S-adenosyl-L-homocysteine + 3 H+
|
 |
 |
 |
 |
 |
L-lysyl(36)-[histone H3]
|
+
|
3
×
S-adenosyl-L-methionine
|
=
|
N(6),N(6),N(6)- trimethyl-L-lysyl(36)-[histone H3]
|
+
|
3
×
S-adenosyl-L-homocysteine
|
+
|
3
×
H(+)
Bound ligand (Het Group name = )
corresponds exactly
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Genes Dev
30:1611-1616
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
|
|
S.Yang,
X.Zheng,
C.Lu,
G.M.Li,
C.D.Allis,
H.Li.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
High-frequency point mutations of genes encoding histones have been identified
recently as novel drivers in a number of tumors. Specifically, the H3K36M/I
mutations were shown to be oncogenic in chondroblastomas and undifferentiated
sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report
the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I
peptides with SAH (S-adenosylhomocysteine). In the complex structure, the
catalytic domain adopts an open conformation, with the K36M/I peptide snuggly
positioned in a newly formed substrate channel. Our structural and biochemical
data reveal the molecular basis underying oncohistone recognition by and
inhibition of SETD2.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|